{
    "bipacksedel": {},
    "produktresume": {},
    "fass_text": {},
    "bilder_och_delbarhet": {},
    "miljöinformation": {
        "env-effect": "Bortezomib Miljörisk: Användning av bortezomib har bedömts medföra försumbar risk för miljöpåverkan. Nedbrytning: Det kan inte uteslutas att bortezomib är persistent, då data saknas. Bioackumulering: Bortezomib har låg potential att bioackumuleras. Läs mer Detaljerad miljöinformation Environmental Risk Classification Predicted Environmental Concentration (PEC) PEC is calculated according to the following formula: PEC (μg/L) = (A*109*(100-R))/(365*P*V*D*100) = 1.37*10-6*A*(100-R) PEC = 0.000022418 µg/L Where: A = total actual API sales in Sweden for the most recent year 0.16363573345 kg (total sold amount API in the most recent sales data for Sweden (2022) was distributed by IQVIA in 2023) R = 0 P = number of inhabitants in Sweden = 10 *106 V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (Reference V) D = factor for dilution of wastewater by surface water flow = 10 (ECHA default) (Reference V) Predicted No Effect Concentration (PNEC) Ecotoxicological studies Algae (Scenedesmus subspicatus) (guideline e.g. OECD 201) [Reference I]: EγC50 72 h (yield) = 0.30 mg/L NOECγ (yield) = 0.10 mg/L ErC50 72 h (growth) = 0.46 mg/L NOECr (growth) = 0.10 mg/L Crustacean (Daphnia magna) (water-flea) (guideline e.g. OECD 202) [Reference II]: Acute toxicity Acute toxicity to water-flea (Daphnia magna) EC50 48 h = 0.45 mg/L (Immobility) NOEC = 0.17 mg/L Chronic toxicity Not available Fish: Acute toxicity Acute toxicity to zebra fish (Brachydanio rerio) (guideline e.g. OECD 203) [Reference III]: LC50 96 h (mortality) = 1.1 mg/L NOEC < 0.46 mg/L Chronic toxicity Not available Other ecotoxicity data: Activated sludge respiration inhibition test (guideline e.g. OECD 209) [Reference IV] EC50 3 h > 1000 mg/L NOEC 3 h = 714 mg/L PNEC (µg/l) = lowest EC50/1000, where 1000 is the assessment factor used. ErC50 for the alga Scenedesmus subspicatus (0.46 mg/L) and EC50 for Daphnia magna (0.45 mg/L) have been used for this calculation since these two species are the most sensitive of the three tested species and for algae, growth is the most reliable endpoint. PNEC = 0.45 mg/L/1000 = 0.45 µg/L Environmental risk classification (PEC/PNEC ratio) PEC/PNEC = 0.000022418/0.45 = 0.00004981 i.e. PEC/PNEC ≤ 0.1 The calculated PEC/PNEC ratio is ≤ 0.1. Use of Bortezomib has been considered to result in insignificant environmental risk. Degradation Biotic degradation Ready degradability: Not available. Inherent degradability: - Simulation studies: Not available. Conclusion for degradation: The potential for persistence of Bortezomib cannot be excluded, due to lack of data. Abiotic degradation Hydrolysis: - Photolysis: - Bioaccumulation Partition coefficient octanol/water: The partition coefficient octanol/water was to determined to be log Kow = 2.8 using unknown internal method. According to ChemSpider ACD/Percepta the log Kow = 2.45. [Reference VI]. Bioconcentration factor (BCF): According to ChemSpider ACD/BCF (pH7.4) = 15.60. [Reference VI] Since BCF < 500, Bortezomib has low potential for bioaccumulation. Conclusion for bioaccumulation: Bortezomib has low potential for bioaccumulation. Excretion (metabolism) - PBT/vPvB assessment PBT-criteria Results for Bortezomib P DT50 freshwater > 40 days or DT50 sediment > 120 days No data available B BCF > 2000 BCF = 15.60 T Chronic NOEC < 0.01 mg/L or CMR or endocrine disrupting NOECalgae = 0.10 mg//L NOECdaphnia = 0.17 mg/L NOECfish = 0.45 mg/L The PBT-criteria are not fulfilled. Therefore, Bortezomib is not considered a PBT-substance. References Peither A., Bortezomib: Toxicity to Scenedsmus subspicatus in a 72-Hour Algal Growth Inhibition Test, OECD 201; RCC Ltd. Study A39958; JnJ Study RMD740; June 30, 2006. Peither A., Bortezomib: Acute Toxicity to Daphnia Magna in a 48-Hour Immobilization Test, OECD 202; RCC Ltd. Study A39971; JnJ Study RMD741; June 30, 2006. Peither A., Bortezomib: Acute Toxicity to Zebra Fish (Brachydanio rerio) in a 96-Hour Static Test, OECD 203; RCC Ltd. Study A39993; JnJ Study RMD742; June 30, 2006. Grützner I., Bortezomib: Toxicity to Activated Sludge in a Respiration Inhibition Test, OECD 209; RCC Ltd. Study A40015; JnJ Study RMD743; March 28, 2006. ECHA, European Chemicals Agency. 2008 Guidance on information requirements and chemical safety assessment. http://guidance.echa.europa.eu/docs/guidance_document/information_requirements_en.htm Bortezomib, ChemSpider, ID # 343402, July 7, 2015, http://www.chemspider.com/Chemical-Structure.343402.html?rid=8f028c39-d830-42ba-a890-e9384a9affab"
    },
    "skyddsinfo": {},
    "product_name": {
        "product_name": "VELCADE®, Pulver till injektionsvätska, lösning 1 mg"
    }
}